tiprankstipranks
Immunic (IMUX)
NASDAQ:IMUX
US Market

Immunic (IMUX) Income Statement

Compare
1,432 Followers

Immunic Income Statement

Last quarter (Q3 2024), Immunic's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Immunic's net income was $-24.37M. See Immunic’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -111.00K$ -77.00K$ -85.00K$ -39.00K$ -50.00K
Operating Expenses
$ 99.22M$ 86.52M$ 91.67M$ 48.97M$ 37.03M
Depreciation and Amortization
$ 111.00K$ 77.00K$ 85.00K$ 39.00K$ 50.00K
EBITDA
$ -99.11M$ -120.33M$ -92.86M$ -48.93M$ -36.98M
Operating Income
$ -99.22M$ -119.49M$ -91.67M$ -48.97M$ -37.03M
Other Income/Expenses
$ 5.61M$ -919.00K$ -1.28M$ 4.95M$ 2.10M
Pretax Income
$ -93.61M$ -120.41M$ -92.94M$ -44.02M$ -34.93M
Net Income
$ -93.61M$ -154.30M$ -92.79M$ -43.96M$ -34.83M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -2.11$ -4.85$ -3.92$ -2.81$ -4.51
Diluted EPS
$ -2.11$ -4.85$ -3.92$ -2.81$ -4.51
Weighted Average Shares Outstanding
44.32M 31.82M 23.65M 15.66M 7.72M
Weighted Average Shares Outstanding (Diluted)
44.32M 31.82M 23.65M 15.66M 7.72M
Currency in USD

Immunic Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis